Literature DB >> 4940084

Sustained-release formulation of prednisolone administered orally to man.

P F D'Arcy, J P Griffin, J S Jenkins, W F Kirk, A W Peacock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4940084     DOI: 10.1002/jps.2600600705

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  6 in total

1.  Bioavailability of prednisolone tablets.

Authors:  A V Tembo; M R Hallmark; E Sakmar; H G Bachmann; D J Weidler; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

Review 2.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

3.  Dose dependent pharmacokinetics of prednisolone.

Authors:  M E Pickup; J R Lowe; P A Leatham; V M Rhind; V Wright; W W Downie
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

4.  Measurement of plasma prednisolone in man.

Authors:  C G Wilson; R Ssendagire; C S May; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

5.  Prednisolone levels in the plasma and urine: a study of two preparations in man.

Authors:  J English; J Chakraborty; V Marks; D J Trigger; A G Thomson
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

6.  Plasma prednisolone measurements in renal transplant patients.

Authors:  J Chakraborty
Journal:  Ulster Med J       Date:  1981
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.